Asymmetric dimethylarginine levels in patients with coronary artery ectasia

Cay S., Cagirci G., Akcay M., Karakurt O., Kahraman E., YAZIHAN N., ...Daha Fazla

KARDIOLOGIA POLSKA, cilt.67, sa.12, ss.1362-1370, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 67 Sayı: 12
  • Basım Tarihi: 2009
  • Dergi Adı: KARDIOLOGIA POLSKA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1362-1370
  • Anahtar Kelimeler: asymmetric dimethylarginine, coronary artery ectasia, endothelial dysfunction, CLINICAL-SIGNIFICANCE, FRAME COUNT, ADMA, DYSFUNCTION, ANEURYSMS, PLASMA, RISK, HPLC
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: Endothelial dysfunction might be one of the pathophysiological mechanisms in the development of coronary artery ectasia (CAE) although the exact mechanisms have not yet been demonstrated. Asymmetric dimethylarginine (ADMA), an endogenous competitive inhibitor of nitric oxide synthase, is also related to endothelial and structural dysfunction.